The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poultry Necrotic Enteritis Drugs Market Research Report 2025
Synopsis
Treatment for necrotic enteritis is most commonly administered in the drinking water, with bacitracin, penicillin, and lincomycin most often used.
Global Poultry Necrotic Enteritis Drugs market is projected to reach US$ 663.6 million in 2029, increasing from US$ 497.4 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Poultry Necrotic Enteritis Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Poultry Necrotic Enteritis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Prometic Life Sciences
BioGaia Probiotics
Fresenius
Actavis
Teva
Bayer International
Alcon
GlaxoSmithKline
Bausch & Lomb Incorporated
Elanco
Merck
Segment by Type
Inter Alpha Inhibitor Proteins
Antibiotics
Dietary Supplements
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Poultry Necrotic Enteritis Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Treatment for necrotic enteritis is most commonly administered in the drinking water, with bacitracin, penicillin, and lincomycin most often used.
Global Poultry Necrotic Enteritis Drugs market is projected to reach US$ 663.6 million in 2029, increasing from US$ 497.4 million in 2022, with the CAGR of 3.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Poultry Necrotic Enteritis Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Poultry Necrotic Enteritis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Prometic Life Sciences
BioGaia Probiotics
Fresenius
Actavis
Teva
Bayer International
Alcon
GlaxoSmithKline
Bausch & Lomb Incorporated
Elanco
Merck
Segment by Type
Inter Alpha Inhibitor Proteins
Antibiotics
Dietary Supplements
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Poultry Necrotic Enteritis Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Poultry Necrotic Enteritis Drugs Market Overview
1.1 Product Overview and Scope of Poultry Necrotic Enteritis Drugs
1.2 Poultry Necrotic Enteritis Drugs Segment by Type
1.2.1 Global Poultry Necrotic Enteritis Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Inter Alpha Inhibitor Proteins
1.2.3 Antibiotics
1.2.4 Dietary Supplements
1.3 Poultry Necrotic Enteritis Drugs Segment by Application
1.3.1 Global Poultry Necrotic Enteritis Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Poultry Necrotic Enteritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Poultry Necrotic Enteritis Drugs Revenue 2018-2029
1.4.2 Global Poultry Necrotic Enteritis Drugs Sales 2018-2029
1.4.3 Global Poultry Necrotic Enteritis Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Poultry Necrotic Enteritis Drugs Market Competition by Manufacturers
2.1 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Poultry Necrotic Enteritis Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Poultry Necrotic Enteritis Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Poultry Necrotic Enteritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poultry Necrotic Enteritis Drugs, Product Type & Application
2.7 Poultry Necrotic Enteritis Drugs Market Competitive Situation and Trends
2.7.1 Poultry Necrotic Enteritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poultry Necrotic Enteritis Drugs Players Market Share by Revenue
2.7.3 Global Poultry Necrotic Enteritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poultry Necrotic Enteritis Drugs Retrospective Market Scenario by Region
3.1 Global Poultry Necrotic Enteritis Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Poultry Necrotic Enteritis Drugs Global Poultry Necrotic Enteritis Drugs Sales by Region: 2018-2029
3.2.1 Global Poultry Necrotic Enteritis Drugs Sales by Region: 2018-2023
3.2.2 Global Poultry Necrotic Enteritis Drugs Sales by Region: 2024-2029
3.3 Global Poultry Necrotic Enteritis Drugs Global Poultry Necrotic Enteritis Drugs Revenue by Region: 2018-2029
3.3.1 Global Poultry Necrotic Enteritis Drugs Revenue by Region: 2018-2023
3.3.2 Global Poultry Necrotic Enteritis Drugs Revenue by Region: 2024-2029
3.4 North America Poultry Necrotic Enteritis Drugs Market Facts & Figures by Country
3.4.1 North America Poultry Necrotic Enteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Poultry Necrotic Enteritis Drugs Sales by Country (2018-2029)
3.4.3 North America Poultry Necrotic Enteritis Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poultry Necrotic Enteritis Drugs Market Facts & Figures by Country
3.5.1 Europe Poultry Necrotic Enteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Poultry Necrotic Enteritis Drugs Sales by Country (2018-2029)
3.5.3 Europe Poultry Necrotic Enteritis Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poultry Necrotic Enteritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Poultry Necrotic Enteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Poultry Necrotic Enteritis Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Poultry Necrotic Enteritis Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poultry Necrotic Enteritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Poultry Necrotic Enteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Poultry Necrotic Enteritis Drugs Sales by Country (2018-2029)
3.7.3 Latin America Poultry Necrotic Enteritis Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poultry Necrotic Enteritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Poultry Necrotic Enteritis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Poultry Necrotic Enteritis Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Poultry Necrotic Enteritis Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Poultry Necrotic Enteritis Drugs Sales by Type (2018-2029)
4.1.1 Global Poultry Necrotic Enteritis Drugs Sales by Type (2018-2023)
4.1.2 Global Poultry Necrotic Enteritis Drugs Sales by Type (2024-2029)
4.1.3 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Poultry Necrotic Enteritis Drugs Revenue by Type (2018-2029)
4.2.1 Global Poultry Necrotic Enteritis Drugs Revenue by Type (2018-2023)
4.2.2 Global Poultry Necrotic Enteritis Drugs Revenue by Type (2024-2029)
4.2.3 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Poultry Necrotic Enteritis Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Poultry Necrotic Enteritis Drugs Sales by Application (2018-2029)
5.1.1 Global Poultry Necrotic Enteritis Drugs Sales by Application (2018-2023)
5.1.2 Global Poultry Necrotic Enteritis Drugs Sales by Application (2024-2029)
5.1.3 Global Poultry Necrotic Enteritis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Poultry Necrotic Enteritis Drugs Revenue by Application (2018-2029)
5.2.1 Global Poultry Necrotic Enteritis Drugs Revenue by Application (2018-2023)
5.2.2 Global Poultry Necrotic Enteritis Drugs Revenue by Application (2024-2029)
5.2.3 Global Poultry Necrotic Enteritis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Poultry Necrotic Enteritis Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Prometic Life Sciences
6.1.1 Prometic Life Sciences Corporation Information
6.1.2 Prometic Life Sciences Description and Business Overview
6.1.3 Prometic Life Sciences Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Prometic Life Sciences Poultry Necrotic Enteritis Drugs Product Portfolio
6.1.5 Prometic Life Sciences Recent Developments/Updates
6.2 BioGaia Probiotics
6.2.1 BioGaia Probiotics Corporation Information
6.2.2 BioGaia Probiotics Description and Business Overview
6.2.3 BioGaia Probiotics Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BioGaia Probiotics Poultry Necrotic Enteritis Drugs Product Portfolio
6.2.5 BioGaia Probiotics Recent Developments/Updates
6.3 Fresenius
6.3.1 Fresenius Corporation Information
6.3.2 Fresenius Description and Business Overview
6.3.3 Fresenius Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Poultry Necrotic Enteritis Drugs Product Portfolio
6.3.5 Fresenius Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Actavis Poultry Necrotic Enteritis Drugs Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Poultry Necrotic Enteritis Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Bayer International
6.6.1 Bayer International Corporation Information
6.6.2 Bayer International Description and Business Overview
6.6.3 Bayer International Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bayer International Poultry Necrotic Enteritis Drugs Product Portfolio
6.6.5 Bayer International Recent Developments/Updates
6.7 Alcon
6.6.1 Alcon Corporation Information
6.6.2 Alcon Description and Business Overview
6.6.3 Alcon Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alcon Poultry Necrotic Enteritis Drugs Product Portfolio
6.7.5 Alcon Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GlaxoSmithKline Poultry Necrotic Enteritis Drugs Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Bausch & Lomb Incorporated
6.9.1 Bausch & Lomb Incorporated Corporation Information
6.9.2 Bausch & Lomb Incorporated Description and Business Overview
6.9.3 Bausch & Lomb Incorporated Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bausch & Lomb Incorporated Poultry Necrotic Enteritis Drugs Product Portfolio
6.9.5 Bausch & Lomb Incorporated Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Corporation Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Elanco Poultry Necrotic Enteritis Drugs Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Merck
6.11.1 Merck Corporation Information
6.11.2 Merck Poultry Necrotic Enteritis Drugs Description and Business Overview
6.11.3 Merck Poultry Necrotic Enteritis Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Merck Poultry Necrotic Enteritis Drugs Product Portfolio
6.11.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poultry Necrotic Enteritis Drugs Industry Chain Analysis
7.2 Poultry Necrotic Enteritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poultry Necrotic Enteritis Drugs Production Mode & Process
7.4 Poultry Necrotic Enteritis Drugs Sales and Marketing
7.4.1 Poultry Necrotic Enteritis Drugs Sales Channels
7.4.2 Poultry Necrotic Enteritis Drugs Distributors
7.5 Poultry Necrotic Enteritis Drugs Customers
8 Poultry Necrotic Enteritis Drugs Market Dynamics
8.1 Poultry Necrotic Enteritis Drugs Industry Trends
8.2 Poultry Necrotic Enteritis Drugs Market Drivers
8.3 Poultry Necrotic Enteritis Drugs Market Challenges
8.4 Poultry Necrotic Enteritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
